Björn Kafsack's Avatar

Björn Kafsack

@kafsacklab.bsky.social

Working at Weill Cornell in New York City at the intersection of chromatin, metabolism, and differentiation in apicomplexan parasites.

93 Followers  |  91 Following  |  19 Posts  |  Joined: 07.02.2025  |  1.9951

Latest posts by kafsacklab.bsky.social on Bluesky

It's missing the long line of mini-figures...

25.06.2025 22:39 — 👍 1    🔁 0    💬 0    📌 0
Post image

I came to the US as an exchange student when I was 16 and have been here ever since. Finally got my citizenship earlier this year, so at age 47, I got to vote for the first time today.

25.06.2025 03:28 — 👍 6    🔁 0    💬 0    📌 0

Never! This heirloom will be passed down to each first-born in perpetuity.

12.06.2025 17:51 — 👍 3    🔁 0    💬 0    📌 0
Post image

He's right. "Nothing short of devastating"
By @holdenthorp.bsky.social @science.org
www.science.org/doi/10.1126/...

05.06.2025 20:41 — 👍 694    🔁 245    💬 12    📌 28

Little confused: Doesn't the letter specifically state that the NIH director lacks the ability to dismiss Advisory Committee members since they serve at the discretion of the HHS secretary?

12.06.2025 16:46 — 👍 0    🔁 0    💬 0    📌 0

Little confused: Doesn't the letter specifically state that the NIH director lacks the ability to dismiss Advisory Committee members since they serve at the discretion of the HHS secretary?

12.06.2025 16:45 — 👍 0    🔁 0    💬 1    📌 0
Post image

Came across this gem from @fad1.bsky.social while packing up my office.

11.06.2025 19:19 — 👍 5    🔁 0    💬 1    📌 0

Great collaboration between GSK Tres Cantos, Weill Cornell and the Sanders Tri-Institutional Therapeutics Discovery Institute.

23.05.2025 15:25 — 👍 1    🔁 0    💬 0    📌 0

Great collaboration between GSK Tres Cantos, Weill Cornell and the Sanders Tri-Institutional Therapeutics Discovery Institute.

23.05.2025 15:24 — 👍 0    🔁 0    💬 0    📌 0

As standard screens for new antimalarials yield diminishing new targets and chemotypes, GSK Tres Cantos used media that mimics nutrients in serum & found many new hits. We then id'ed the targets and, amazingly, every one of the 29 new chemotypes found blocks PSAC!🤯
shorturl.at/dCCO8

23.05.2025 15:24 — 👍 3    🔁 0    💬 2    📌 0
Post image 27.03.2025 14:18 — 👍 3    🔁 0    💬 0    📌 0
Post image

The end of the Joe Visone era at WCM is upon us!
It's been an absolute delight! 😍

27.03.2025 14:18 — 👍 7    🔁 0    💬 2    📌 0

Just substituted "transgenic" for "genetically modified" and "diverse/diversity" for "varied/variation" in all parts of my R01 submission. 🤯

19.03.2025 03:01 — 👍 2    🔁 0    💬 0    📌 0

Pulling the F31 Diversity applications from evaluation instead of converting them to regular F31s is just so cruel.

13.03.2025 18:49 — 👍 4    🔁 0    💬 0    📌 0

So sorry for everyone who worked so hard putting their applications together for them be vaporized by the vicissitudes of these malicious minds.

13.03.2025 18:47 — 👍 1    🔁 0    💬 1    📌 0

The NIH just pulled all the F31 Diversity fellowship applications from the study section I'm on ...

13.03.2025 18:44 — 👍 5    🔁 3    💬 1    📌 0
Juan Luis Guerra - La Bilirrubina (Live)
YouTube video by JuanLuisGuerraVEVO Juan Luis Guerra - La Bilirrubina (Live)

www.youtube.com/watch?v=McV4...

28.02.2025 14:46 — 👍 0    🔁 0    💬 0    📌 0

Exciting pre-print from the Soares Lab at the Gulbenkian Institute for Molecular Medicine showing that increased bilirubin is protective in humans, mice and in vitro. 👏👏👏
www.biorxiv.org/content/10.1...

www.youtube.com/watch?v=McV4...

28.02.2025 14:46 — 👍 0    🔁 0    💬 1    📌 0

Does that link work for anyone else?

14.02.2025 14:08 — 👍 0    🔁 0    💬 1    📌 0

Really cool work! Thanks for a great talk ParaFrap and Gretchen.

13.02.2025 21:10 — 👍 1    🔁 0    💬 0    📌 0

“Two-thirds of the staff of the President’s Malaria Initiative…the largest donor to anti-malaria programs…worldwide, have been fired…incl some of the most senior and respected scientists working on malaria control in the world.”

02.02.2025 14:33 — 👍 241    🔁 53    💬 4    📌 6

@kafsacklab is following 20 prominent accounts